Development and Validation of a Noninvasive Model of Mixed Venous Oxygen Saturation in Heart Failure.

McDiarmid, AK.; Chambers, BS.; Broadbent, DA.; Patel, R.; Matthews, G.; Gonzalez-Fernandez, O.; Plein, S.; Garg, P.; Swoboda, PP.

Development and Validation of a Noninvasive Model of Mixed Venous Oxygen Saturation in Heart Failure.

All Authors

McDiarmid, AK.

Chambers, BS.

Broadbent, DA.

Patel, R.

Matthews, G.

Gonzalez-Fernandez, O.

Plein, S.

Garg, P.

Swoboda, PP.

LTHT Author

Broadbent, David
Patel, Roshan

LTHT Department

Medical Physics & Engineering
Radionuclide & MRI Physics
Cardio-Respiratory
Cardiology

Non Medic

Clinical Scientist - MRI Physics

Publication Date

2026

Item Type

Journal Article

Subject

MAGNETIC RESONANCE IMAGING , CARDIAC CATHETHERISATION , HEART FAILURE

Abstract

BACKGROUND: Mixed venous oxygen saturation (SvO2), measured with right heart catheterization, is a crucial prognostic tool in patients with heart failure. The prognostic significance of SvO2 estimated noninvasively using cardiovascular magnetic resonance (CMR) from the T2 of intracardiac blood pools remains unknown. OBJECTIVES: The objective of the study was to develop a CMR model of mixed venous saturation (imaging-derived SvO2 [iSvO2]), and establish if it is associated with future adverse events in heart failure. METHODS: The iSvO2 was modeled in the discovery cohort (N = 30), who underwent CMR T2 mapping and invasive right heart catheterization, by linear regression. The validation cohort of 628 patients with recently diagnosed heart failure underwent clinical assessment, CMR, and follow-up (median 3 years [IQR: 1.5-4.8]) for a primary endpoint of all-cause mortality or heart failure hospitalization. RESULTS: Significant positive correlation was found between the ratio of right ventricular blood pool T2/left ventricular blood pool T2 and invasive mixed venous oxygen saturation (R = 0.82; 95% CI: 0.66-0.91; P < 0.001), giving the equation: iSvO2 = 95.(RV-T2BP/LV-T2BP). In the validation cohort, there was a strong association between iSvO2 and the primary endpoint (HR: 0.66 for 10% change in iSvO2; 95% CI: 0.54-0.81; P < 0.001), which remained significant after adjusting for age, sex, left ventricular ejection fraction, right ventricular ejection fraction, N-terminal pro-B-type natriuretic peptide, NYHA functional class, and diabetes. CONCLUSIONS: The CMR iSvO2, measured from simple T2 maps of left and right ventricular blood pool, allows accurate estimation of the invasive SvO2. In a real-world heart failure registry, iSvO2 is an independent predictor of mortality and heart failure hospitalization. Copyright © 2026 The Authors. Published by Elsevier Inc. All rights reserved.